Literature DB >> 25741953

Pharmacotherapy of sepsis.

David J Pavlik1, Robert W Simpson, Edward T Horn, Lauren King, Lauren Finoli.   

Abstract

Treatment of sepsis involves prompt recognition and treatment to optimize outcome. Several medication considerations are pertinent to patients with sepsis, severe sepsis, and septic shock. Medications play a crucial role in providing resuscitation, hemodynamic support, resolution of infection, and reduction of complications of the disease. Over the past 20 years, significant focus has been devoted to the pharmacologic treatment of septic shock, resulting in significant advances and controversies. Ongoing research will continue to focus on this disease process and will continue to shape treatment in the future. The use of medication therapies directed at treatment of sepsis will be reviewed in this article.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25741953     DOI: 10.1097/CNQ.0000000000000053

Source DB:  PubMed          Journal:  Crit Care Nurs Q        ISSN: 0887-9303


  1 in total

1.  RX-207, a Small Molecule Inhibitor of Protein Interaction with Glycosaminoglycans (SMIGs), Reduces Experimentally Induced Inflammation and Increases Survival Rate in Cecal Ligation and Puncture (CLP)-Induced Sepsis.

Authors:  Stefan Juhas; Nicholas Harris; Gabriela Il'kova; Pavol Rehák; Ferenc Zsila; Faina Yurgenzon Kogan; Orly Lahmy; Regina Zhuk; Paul Gregor; Juraj Koppel
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.